{ "items": [ "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Profile\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n PGCert in TEBHC: surfacing again after a major challenge\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Veerle\n \n
\n \n \n \n \n

\n \n \n Veerle Langenhorst\n \n \n

\n \n\n \n

\n 29 January 2021\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Oxford\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n COVID-19 pandemic: Can the cultural and heritage sectors support older people\u2019s well-being through social prescribing?\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Stephanie\n \n
\n \n \n \n \n

\n \n \n Stephanie Tierney, \n \n \n \n \n Kamal R. Mahtani\n \n \n

\n \n\n \n

\n 29 January 2021\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Group\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n Is the COVID pandemic creating \u201cVortex Leadership\u201d?\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Kamal\n \n
\n \n \n \n \n

\n \n \n Kamal R. Mahtani, \n \n \n \n \n Sean Heneghan\n \n \n

\n \n\n \n

\n 11 November 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"full-length\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n Learning in the time of coronavirus\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 2 November 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Student\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n Student Spotlight: Nicholas Nyaaba\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 29 October 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Nicholas Nyaaba shares his experience, having recently completed his dissertation on the MSc in EBHC Medical Statistics.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Mike\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n This Is Oxford: moving the MSc in EBHC Systematic Reviews modules online\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Mike\n \n
\n \n \n \n \n

\n \n \n Mike Clarke\n \n \n

\n \n\n \n

\n 27 October 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Professor Mike Clarke, shares his teaching experience, having moved the EBHC MSc Systematic Reviews modules online this term.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Paper\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n The potential of social prescribing to support people diagnosed with mild cognitive impairment\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Stephanie\n \n
\n \n \n \n \n

\n \n \n Stephanie Tierney\n \n \n

\n \n\n \n

\n 25 October 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Orange\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n High-dose opioids: five factors that increase the risk of harm\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Georgia\n \n
\n \n \n \n \n

\n \n \n Georgia Richards\n \n \n

\n \n\n \n

\n 23 August 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

DPhil student Georgia Richards argues why it\u2019s time for doctors to rethink the prescribing of high-dose opioids for people with chronic pain.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Young\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n Coronavirus and diabetes: the different risks for people with type 1 and type 2\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 23 August 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

People with type 1 diabetes are approximately 3.5 times as likely to die in hospital with COVID-19, while people with type 2 are approximately twice as likely, but why is this, and what can be done to reduce this risk?

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Patient\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n Nicotine therapy for coronavirus: the evidence is weak and contradictory\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 23 August 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

We are unlikely to know whether nicotine replacement has a role in COVID-19 any time soon. For now, nicotine supplies must be preserved for the people who need them.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Ranin\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n Ranin Soliman: evidence resonates with qualitative research\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 20 August 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Ranin Soliman, DPhil Student in EBHC, describes her experience of the qualitative research methods module.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n What does effective leadership mean to YOU?\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Kamal\n \n
\n \n \n \n \n

\n \n \n Kamal R. Mahtani, \n \n \n \n \n Sean Heneghan\n \n \n

\n \n\n \n

\n 30 June 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Recent world events have highlighted leadership in a variety of ways. For some, it has been an opportunity to excel by applying the right characteristics at the right time and in the right way. Others have been less successful in how their leadership has been perceived.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Can you recognise the \u201cIN\u201d and \u201cOUT\u201d leaders?\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Kamal\n \n
\n \n \n \n \n

\n \n \n Kamal R. Mahtani, \n \n \n \n \n Sean Heneghan\n \n \n

\n \n\n \n

\n 29 June 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"David\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n PGCert Teaching Evidence-Based Health Care Update\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"David\n \n
\n \n \n \n \n

\n \n \n David Nunan\n \n \n

\n \n\n \n

\n 12 June 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

PgCert Teaching Evidence-Based Health Care Course Director, Dr David Nunan, reflects on the first year of the course, and maintaining delivery during the pandemic.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Leadership in COVID-19: The dangers of groupthink in crisis leadership\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Kamal\n \n
\n \n \n \n \n

\n \n \n Kamal R. Mahtani, \n \n \n \n \n Sean Heneghan\n \n \n

\n \n\n \n

\n 26 May 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Leadership in COVID-19: What can history teach us about crisis leadership?\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Kamal\n \n
\n \n \n \n \n

\n \n \n Kamal R. Mahtani, \n \n \n \n \n Sean Heneghan\n \n \n

\n \n\n \n

\n 7 May 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Leadership in covid-19: building public trust is key\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Kamal\n \n
\n \n \n \n \n

\n \n \n Kamal R. Mahtani\n \n \n

\n \n\n \n

\n 5 May 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n PaT Plot tool for randomised trials\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 4 May 2020\n \n

\n \n\n \n \n
\n \n \n\n\n \n \n

This page is about PaT Plot, a software tool for creating graphic depictions of randomised trials.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Composite\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n Cultural environments can improve health and wellbeing through 'social prescribing'\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Kamal\n \n
\n \n \n \n \n

\n \n \n Kamal R. Mahtani\n \n \n

\n \n\n \n

\n 12 March 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n What does it take to be a leader in evidence-based healthcare?\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Kamal\n \n
\n \n \n \n \n

\n \n \n Kamal R. Mahtani\n \n \n

\n \n\n \n

\n 27 February 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n PGCert in TEBHC: thoughts from a current student\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Veerle\n \n
\n \n \n \n \n

\n \n \n Veerle Langenhorst\n \n \n

\n \n\n \n

\n 24 February 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Paediatrician Veerle Langenhorst gathers some thoughts about her current PGCert in TEBHC experience.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Challenging our teaching in evidence-based medicine. A risk worth taking\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"David\n \n
\n \n \n \n \n

\n \n \n David Nunan\n \n \n

\n \n\n \n

\n 17 February 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n PGDip in Health Research: Reflections on 10 years\n

\n\n\n \n\n \n \n
\n \n \n \n \n \n \n \n \n

\n \n \n Denise Best\n \n \n

\n \n\n \n

\n 14 February 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Denise reflects on the creation of the PGDip in Health Research and its impact over the last ten years.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Advanced Qualitative Research Methods: student experience\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 7 February 2020\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Academic Clinical Fellow in Palliative Medicine, Dr Joe Sawyer, reflects on his experience of our Advanced Qualitative Research Methods module.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n The rise and rise of realist reviews?\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Geoff\n \n
\n \n \n \n \n

\n \n \n Geoff Wong\n \n \n

\n \n\n \n

\n 28 October 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Realist reviews are becoming an increasing popular approach to synthesising evidence about complex interventions. Whilst Geoff welcomes this increase, he raises challenges that such popularity might bring

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Orange\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n Diagnostic tests for bacterial infections in older adults - unexpected results!\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 22 August 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Low-dose ketamine can be effective in reducing post-operative pain\n

\n\n\n \n\n \n \n
\n \n \n \n \n \n \n \n \n

\n \n \n J Mark Riddell\n \n \n

\n \n\n \n

\n 31 July 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Do journals really care about bias and reporting in clinical trials?\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 25 July 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Should we be using credible intervals more routinely?\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Jason\n \n
\n \n \n \n \n

\n \n \n Jason Oke, \n \n \n \n \n Luke Allen\n \n \n

\n \n\n \n

\n 23 July 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n 'Rejection is part of the process'\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Anne-Marie\n \n
\n \n \n \n \n

\n \n \n Anne-Marie Boylan\n \n \n

\n \n\n \n

\n 22 July 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Rejection is part of the process: Turning your dissertation into an academic paper

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Trials published fail to adequately report risk estimates\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 22 July 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

76% of recent trials published in the top five medical journals fail to adequately report risk assessments, find 6th-Year Medical Students Izzy, Furqaan and Shanil.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n PEBM in a resource-limited country\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Wangari\n \n
\n \n \n \n \n

\n \n \n Wangari Waweru-Siika\n \n \n

\n \n\n \n

\n 17 June 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Practising Evidence-Based Medicine in a Resource-limited country: let's start at the very beginning

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n The Creation of the Oxford-Brazil EBM Alliance\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"David\n \n
\n \n \n \n \n

\n \n \n David Nunan\n \n \n

\n \n\n \n

\n 12 June 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"students\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n Why you should take part in a DPhil in EBHC seminar\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 28 May 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Jong-Wook Ban and Paul Dijkstra, DPhil EBHC students

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n The James Lind Library's Explanatory Essays: new downloadable book\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 22 May 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n How to deliver teaching that gets to the P in Evidence Based Practice\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Edmund\n \n
\n \n \n \n \n

\n \n \n Edmund Jack\n \n \n

\n \n\n \n

\n 9 May 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Thinking about meta-synthesis and its proliferation over recent years\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Stephanie\n \n
\n \n \n \n \n

\n \n \n Stephanie Tierney\n \n \n

\n \n\n \n

\n 1 April 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Numbers don't count - methods do\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Anne-Marie\n \n
\n \n \n \n \n

\n \n \n Anne-Marie Boylan, \n \n \n \n \n David Nunan, \n \n \n \n \n Veronika Williams\n \n \n

\n \n\n \n

\n 25 March 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Why we need to reshape critical appraisal and develop tools that allow differentiated evaluations of the myriad of qualitative methodological approaches

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Bacterial skin infections in older adults- don't make a rash diagnosis...\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 15 March 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n How can we get value-based healthcare?\n

\n\n\n \n\n \n \n
\n \n \n \n \n \n \n \n \n

\n \n \n Louise Hurst\n \n \n

\n \n\n \n

\n 15 February 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Louise Hurst, Senior Associate Tutor and Senior Research Fellow in Public Health\r\nCentre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Salt reduction in heart failure: where has the uncertainty come from?\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"David\n \n
\n \n \n \n \n

\n \n \n David Nunan\n \n \n

\n \n\n \n

\n 4 February 2019\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Teaching evidence-based medicine: where next?\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"David\n \n
\n \n \n \n \n

\n \n \n David Nunan\n \n \n

\n \n\n \n

\n 22 November 2018\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n The death of King Charles II\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Jeffrey\n \n
\n \n \n \n \n

\n \n \n Jeffrey K Aronson, \n \n \n \n \n Carl Heneghan\n \n \n

\n \n\n \n

\n 17 October 2018\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Charles II was born on 29 May 1630 to Charles I and his French wife, Henrietta Maria, and died on 6 February 1685. Here Jeff Aronson describes Charles\u2019s final illness and suggests that his death was hastened by his doctors.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Opioids for pain: what's the problem?\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Georgia\n \n
\n \n \n \n \n

\n \n \n Georgia Richards\n \n \n

\n \n\n \n

\n 27 September 2018\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

The long-term use of opioids for pain: what\u2019s the problem?\r\n\r\nPeople receiving long-term pain relief for low back pain gain no benefits from opioids. Georgia Richards discusses her research on why this might be the case.

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Photograph\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n Unhealthy Times of Kings and Queens\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Carl\n \n
\n \n \n \n \n

\n \n \n Carl Heneghan, \n \n \n \n \n Jeffrey K Aronson\n \n \n

\n \n\n \n

\n 25 September 2018\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

We have put together an exhibition of the Kings and Queens, their illnesses, their deaths, and the public health messages their stories portray. The messages include preventable diseases such as obesity, smoking, and vaccination for smallpox, along with the problems of overtreatment, its consequences and its effect on speeding up the death of some of the monarchs.\r\nCarl Heneghan, Director Centre for Evidence-Based Medicine

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n The Prosecutor's Fallacy\n

\n\n\n \n\n \n \n
\n \n \n \n \n \n \n \n \n

\n \n \n Kathy Taylor\n \n \n

\n \n\n \n

\n 16 July 2018\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Don't ditch p-values: understand them\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 23 May 2018\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

\u2018When did we start thinking that a single study was enough to prove a scientific hypothesis?\r\n\r\nRichard Stevens, Director of the MSc in EBHC Medical Statistics

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n
\n \n \n\n \n
\n
\n \n\n \n \n \"Profile\n \n \n\n\n
\n \n
\n \n\n\n \n
\n \n \n
\n \n\n

\n Trade Secrets of a DPhil in Evidence-Based Health Care\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Marcy\n \n
\n \n \n \n \n

\n \n \n Marcy McCall MacBain\n \n \n

\n \n\n \n

\n 23 April 2018\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Perspectives from Marcy McCall MacBain, DPhil (Oxon)

\n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Does a pomegranate a day keep your blood pressure at bay?\n

\n\n\n \n\n \n \n
\n \n \n \n
\n \n \"Igho\n \n
\n \n \n \n \n

\n \n \n Igho Onakpoya\n \n \n

\n \n\n \n

\n 18 September 2017\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n \n \n
\n \n
\n\n
\n\n\n", "\n\n
\n \n
\n\n \n \n
\n \n\n

\n Continuous Glucose Monitoring for the iPhone Generation?\n

\n\n\n \n\n \n \n
\n \n \n \n \n\n \n

\n 17 July 2017\n \n

\n \n\n \n\t \n\n \n \n \n\n \n\n\n \n \n
\n \n \n\n\n \n \n

Early CGM devices were expensive and had problems with accuracy and reliability, and patients often needed to provide finger-prick data to keep them. Modern CGMs are smaller and cheaper, but are they reliable?

\n \n
\n \n
\n\n
\n\n\n" ], "more": "\n\n \n \n Load More\n \n \n\n", "msg": "" }